Omeros reported $39.51M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US USD 15.65M 2.04M
Adma Biologics ADMA:US USD 44.44M 16.37M
Alnylam Pharmaceuticals ALNY:US USD 772.79M 115.11M
Biomarin Pharmaceutical BMRN:US USD 521.02M 56.29M
Cytokinetics CYTK:US USD 76.5M 9.65M
Dynavax Technologies DVAX:US USD 244.08M 101.12M
Gilead Sciences GILD:US USD 11.24B 814M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Insmed INSM:US USD 137.65M 23.84M
Intercept Pharmaceuticals ICPT:US USD 221.58M 70.16M
Knight Therapeutics Inc GUD:CN CAD 139.53M 13.5M
Macrogenics MGNX:US USD 50.05M 831K
Mirati Therapeutics MRTX:US USD 126.99M 7.84M
Omeros OMER:US USD 39.51M 1.01M
Pacira Pharmaceuticals PCRX:US USD 131.53M 1.65M
Regulus Therapeutics RGLS:US USD 10.52M 4.69M
Rockwell Medical RMTI:US USD 19.34M 803K
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Sarepta Therapeutics SRPT:US USD 602.92M 57.35M
United Therapeutics UTHR:US USD 315.9M 15.6M
Vital Therapies VTL:US USD 11.51M 1.11M
Xoma XOMA:US USD 5.42M 3M